Skip to main content

NEWSBRIEF: Agencourt To Provide SNP Services For Duke

NEW YORK, May 13-Agencourt Bioscience will provide SNP genotyping services and develop pharmacogenomic markers for the Duke University Medical Center Department of Anesthesiology, the company said today.


The research program will probe the causes of post-surgical organ dysfunction.  Agencourt will use its Sequenom mass spectrometry genotyping platform and its own genomic services capabilities to identify potential new therapeutic targets.


Agencourt and Duke did not divulge rights or financial details, and did not say how many samples would be processed through this arrangement.


"More and more of these [genotyping] studies are coming about," said Agencourt vice president and chief scientific officer Kevin McKernan. "More hospitals are having these studies lined up than biotech."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.